Texas Instruments: The $6.5 Billion Cash-Flow Machine Is Finally Awake

Texas Instruments: The $6.5 Billion Cash-Flow Machine Is Finally Awake

Ryan Canady 672 Followers Follow Summary Texas Instruments is entering a broad-based recovery, evidenced by strong Q2 2026 results and a clear operational turnaround. Q2 2026 saw revenue up 23%, operating profit up 48%, and net income up 53%, signaling robust margin expansion. TXN’s heavy capex cycle is ending, with free cash flow up 56% and capital expenditures nearly halved year-over-year. The company is poised to capitalize on past manufacturing investments, shifting from construction spending to sustained free cash flow generation. gentlelight/iStock via Getty Images When Texas Instruments ( TXN ) reported Q2 2026 earnings on July 22, 2026, it demonstrated that there is a broad-based recovery taking place throughout the company. After reviewing the numbers, I feel that there is no other legitimate conclusion This article was written by Ryan Canady 672 Followers Follow Investing wisely does not have to be rocket science. It is about discipline and running the numbers. You don't have to be like a grandmaster chess player playing the game twenty moves ahead of your opponent, you just need to understand how the pieces work. Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that do include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.